(Circulation. 1995;92:31-36.)
© 1995 American Heart Association, Inc.
Articles |
Improved Preservation of Saphenous Vein Grafts by the Use of Glyceryl Trinitrate–Verapamil Solution During Harvesting
From the Baker Medical Research Institute (N.R., F.L.R., S.M.R.), Melbourne, and Alfred Hospital (F.L.R., R.A.J.C., B.B.D.), Melbourne, Australia.
Correspondence to Dr FL Rosenfeldt, Baker Medical Research Institute, PO Box 348, Prahran, Victoria 3181, Australia.
Background High-pressure distension during harvesting damages the saphenous vein (SV) and may contribute to subsequent coronary artery bypass graft (CABG) occlusion. Application of vasodilator agents to the SV during harvesting may reduce the need for high-pressure distension and improve graft quality. We tested the effects of a vasodilator solution containing glyceryl trinitrate and verapamil (GV) or the conventional agent papaverine (Pap) on the pressure necessary to overcome SV spasm and on the structure and biochemistry of the SV graft.
Methods and Results Thirty-six patients undergoing CABG were randomly allocated to receive an application of either topical and intraluminal GV solution, topical Pap, or topical and intraluminal Ringer's solution (untreated) to the SV during harvesting. The peak and mean pressures required to distend the vein were recorded. Samples of SV were taken for microscopy and biochemical analysis just before we performed the anastomosis. The percentage of endothelial coverage was calculated by area measurements of stained en face preparations of the vein intima. The results for peak pressures (mm Hg) were: untreated, 479.2±27.5; Pap, 384.8±29.0; and GV, 309.5±28.3 (P<.001, GV plus Pap versus untreated); and the results for mean pressures (mm Hg) were untreated, 136.2±9.6; Pap, 102.2±10.8; and GV, 98.0±8.3 (P<.01, GV plus Pap versus untreated). The results for endothelial cover (%) were: untreated, 43.7±7.0; Pap, 44.1±9.2; and GV, 68.7±7.0 (P<.05, GV versus Pap); and the results for ATP (nmol/g wet wt) were: untreated, 67.3±12.7; Pap, 112.0±19.4; and GV, 132.5±22.7 (P<.05, GV plus Pap versus untreated).
Conclusions First, pharmacological treatment of SV during harvesting, especially with GV solution, allows the use of a lower distension pressure and reduces the breakdown of high-energy phosphates in the vein wall. Second, topical and intraluminal use of GV solution during vein harvesting improves endothelial coverage compared with the topical use of Pap or no pharmacological treatment.
Key Words: veins • grafts • bypass • nitrogylcerin • vasodilation
This article has been cited by other articles:
 |
|
 |
|
  M. R. Dashwood, K. Savage, A. Dooley, X. Shi-Wen, D. J. Abraham, and D. S.R. Souza Effect of Vein Graft Harvesting on Endothelial Nitric Oxide Synthase and Nitric Oxide Production Ann. Thorac. Surg., September 1, 2005; 80(3): 939 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wackenfors, R. Ingemansson, and M. Malmsjo Endothelin receptors in endothelium-denuded human coronary artery bypass grafts and coronary arteries Ann. Thorac. Surg., March 1, 2003; 75(3): 874 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Gardner, J. R. Lehmann, and D. L. Costa Oil Fly Ash-Induced Elevation of Plasma Fibrinogen Levels in Rats Toxicol. Sci., July 1, 2000; 56(1): 175 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Galea, J Armstrong, S.E Francis, G Cooper, D.C Crossman, and C.M Holt Alterations in c-fos expression, cell proliferation and apoptosis in pressure distended human saphenous vein Cardiovasc Res, November 1, 1999; 44(2): 436 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Antman and R. Handin Low-Molecular-Weight Heparins : An Intriguing New Twist With Profound Implications Circulation, July 28, 1998; 98(4): 287 - 289. [Full Text] [PDF]
|
|
|
|
|
|
G. Montalescot, F. Philippe, A. Ankri, E. Vicaut, E. Bearez, J. E. Poulard, D. Carrie, D. Flammang, A. Dutoit, A. Carayon, et al. Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery Disease : Beneficial Effects of Enoxaparin Circulation, July 28, 1998; 98(4): 294 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ribichini, G. Steffenino, A. Dellavalle, G. Matullo, E. Colajanni, T. Camilla, A. Vado, G. Benetton, E. Uslenghi, and A. Piazza Plasma Activity and Insertion/Deletion Polymorphism of Angiotensin I–Converting Enzyme : A Major Risk Factor and a Marker of Risk for Coronary Stent Restenosis Circulation, January 20, 1998; 97(2): 147 - 154. [Abstract] [Full Text] [PDF]
|
|